The emphasis on the differences between therapeutic agent for COPD may be misplaced if the drug isn’t actually getting to where it’s needed, and there are calls for more focus on choosing the device. This was the message at a sponsored symposium, held during the 2019 European Respiratory Society (ERS) Congress: “Putting the patient needs ...
Device ahead of drug in an era of improved drug delivery
19 May 2020
Sponsored by Boehringer Ingelheim Pty Ltd